Cytogenetic abnormalities in Langerhans cell histiocytosis. by Betts, D. R. et al.
British Journal ofCancer(1998) 77(4), 552-555
© 1998 Cancer Research Campaign
Cytogenetic abnormalities in Langerhans cell
histiocytosis
DR Betts1, KE Leibundgut2, A Feldges3, HJ P15ss1 and FK Nigglil
'Department of Oncology, University Children's Hospital, CH-8032 Zurich; 2Department of Oncology, University Children's Hospital, CH-3010 Berne;
3Department of Oncology, Children's Hospital, CH-9006 St Gallen, Switzerland
Summary We present the cytogenetic investigations of five histiocytic tumour lesions from children. In four cases there was a confirmed
diagnosis of Langerhans cell histiocytosis (LCH) and one case of histiocytosis that did not fulfil all the criteria for true LCH. All five cases
showed cytogenetic abnormalities, including the first report of an abnormal clone in LCH. The clone showed at(7;12)(qll .2;p13) translocation
and was detected in only a small percentage of cells. This case and a further three also contained non-clonal abnormalities and an increase
in chromosome breakage. The fifth case, the only one in which no acquired abnormalities were seen, had a constitutional paracentric
inversion of chromosome 13q.
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Langerhans cell histiocytosis (LCH) is a histiocytic proliferative
disorder, formally called histiocytosis X by Lichtenstein in 1953
to integrate eosinophilic granuloma, Hand-Schuller-Christian
disease, and Letterer-Siwe disease under a single nosologic entity.
The aetiology and pathogenesis of the disease are still poorly
understood. However, the criteria for the diagnosis and clinical
classification ofLCH has now been clearly defined by the Writing
Group of the Histiocyte Society (1987). The disease has a clinical
heterogeneity ranging from a potentially lethal leukaemia-like
disorder, which primarily affects infants, to solitary lytic bone
lesions. The intermediate forms ofthe disease are characterized by
skin andbone lesions, varying forms oforgan dysfunction, diabetes
insipidus and a chronic indolent course. In all forms of LCH, the
histopathological lesions are typically similar and are characterized
by CDla antigen positive histiocytes and the presence of Birbeck
granules. Positive immunohistochemical staining for the S100
protein is frequent. It has been stated recently that despite a good
survival rate, many LCH patients will have either further disease
dissemination or late sequelae (Willis et al, 1996).
It was reported by Greenberger et al (1981) that in long-term
survivors there was a 5% incidence of malignancy. It has been
suggested that there is an association between LCH and an
increased frequency of malignancy occurring (Egeler et al, 1993).
This includes a high incidence of leukaemia that follows two
distinct patterns (Egeler et al, 1994): acute lymphoblastic
leukaemia tending to precede LCH, whereas acute myeloid
leukaemia (AML) follows. The occurrence of AML may in some
part be related to the treatment of LCH with VP16. However, in
the study of Gadner et al (1994) with a cohort of 106 patients, no
second malignancies were found within a follow-up of4-8 years.
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It has long been considered that LCH is a reactive disorder of
immune regulation rather than a neoplastic process. However, this
idea has been challenged recently by the demonstration that
LCH is a clonal disease (Yu et al, 1994; Willman et al, 1994).
Nonetheless, there is still a lack of other evidence to support a
neoplastic process. One further proof for clonality would be the
evidence ofT-cell rearrangements, but none were found by Yu and
Chu (1995). Tumours are typically characterized by cytogenetic
abnormalities and, in many instances, DNA aneuploidy. To date,
only a small number of LCH lesions have been described with an
abnormal DNA index (Rabkin et al, 1988; Ornvold et al, 1990),
and it has been stated that there is typically a failure to obtain
metaphases and to detectkaryotypic abnormalities in lesional cells
(Willman, 1994).
We present five cases of histiocytosis in which karyotypic
analysis revealed either an abnormal clone, non-clonal abnormali-
ties or a constitutional abnormality.
PATIENTS AND METHODS
The five children represent a consecutive series of patients with a
histiocytosis, in which material was provided for cytogenetic
analysis from different hospitals. All cases were analysed at diag-
nosis, with the exception of case 2, which was investigated 1 year
after diagnosis. Microscopic evaluation of the lesion was clearly
compatible with a LCH (class I histiocytosis) in four out of five
cases. The fifth case had a clinical presentation typical for LCH
but did not fulfil all the histological criteria.
Patient 1, a 2 and 3/12-year-old boy who presented with a soft-
tissue tumour(4 x 4 cm) on the left frontotemporal side ofhis head.
A magnetic resonance imaging (MRI) scan revealed bony destruc-
tion under the tumour mass. The tumour was grossly resected and
histology showed a typical eosinophilic granuloma. Immuno-
histochemistry was positive for CDla antigen and S100 protein.
Further investigations revealed no additional bony or other organ
lesions. The boy remains well 27 months after diagnosis.
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Table 1 Karyotypic results of the five cases
Case Source of cells Time in culture (days) Karyotype Non-clonal abnormalities
1 Le 1-8 46,XY[27] add(6)(q25)/
del(7)(pl?)/
del(7)(q22)/
add(9)(q22)/
-16,+2mar/
-C,+mar
2 Le 20 46,XY[43] der(11)add(11)(pll .2)add(11)(q22),dic(14;?)(pl1;?),
-15,-18,+mar
BM 1 46,XY[50]
3 Le 1-5 46,XY,t(7;12)(ql 1.2;p13)[2y46,XY[45] add(1)(q12),-16,-17,+der(?)t(?;17)(?;ql 1.2),+mar/
t(2;4)(p21;q33),add(13)(pll .2)/
-11,-16,-22,+mar
4 Le 6 46,XY[10] del(8)(p12),-15,-20,+mar/
der(19)?t(9;19)(q12;q13)
5 Le 20 46,XY,inv(13)(q21q33)c[10]
BM 1-3 46,XY,inv(13)(q21q33)c[20]
PB 3 46,XY,inv(13)(q21.2q33)mat
Le, histiocytic lesion; BM, bone marrow; PB, perpheral blood.
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Figure 1 A karyotype of a non-clonal abnormal metaphase from case 3, 46,XY,t(2;4)(p21;q33),add(13)(pll.2)
Patient 2 was diagnosed as a LCH at the age of 1 year with
multiple organ involvement including skin, intestinal tract and
later bone marrow. All the lesions showed eosinophilic cells and
histiocytic elements that stained positive for CDla antigen and
S100 protein. He was treated with chemotherapy but suffered
multiple relapses. To control his disease he finally underwent an
allogeneic bone marrow transplantation 16 months after diagnosis
and achieved acompleteremission in which he remains 18 months
after transplantation.
Patient 3, a 15-year-old boy who presented initially with a torti-
collis and laterdeveloped adecreasedmobility ofhis left shoulder.
A radiograph revealed a lytic lesion in the cervical vertebral body
CS and a soft tissue component comprising the nerve roots C4/C5.
A decompression was performed and microscopic examination
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Figure 2 Normal chromosome 13 and inverted chromosome 13 from the
peripheral blood of case 5 (breakpoints are arrowed)
showed an eosinophilic granuloma with CDla antigen-positive
and S100 protein-positive cells. Chemotherapy was introduced
according to the international LCH II protocol and the patient
achieved remission.
Patient 4 was diagnosed as LCH at the age of9 years with a lytic
lesion in his femur. After the biopsy the patient achieved a sponta-
neous remission. Histology showed a dense granulation tissue with
eosinophilic granulocytes. The typical histiocytic elements
revealed positivity for the immunohistochemical staining of the
CDla antigen and S100 protein.
Patient 5, a phenotypically normal boy who was born one week
late after an uneventful pregnancy to unrelated parents. There was
no reported family history of tumours. At the age of 5 months he
developed a tumour on his frontal cranium, growing from the scalp
to the meningeal membrane. The histology of the biopsy showed
an eosinophilic granuloma but immunohistochemistry did not
show CDla antigen-positive cells or S100 protein positivity. A
histiocytosis could be diagnosed but the biopsy did not fulfil the
criteria for a true LCH. A juvenile xanthogranuloma (class II
histiocytosis) could be the differential diagnosis. Owing to
continued tumour growth after resection, treatment according to
the international LCH II protocol was commenced.
Infiltrated tissue from all five cases was mechanically dissoci-
ated with scalpels to create material suitable for short- and long-
term cultures. The cells were cultured in Nut.Mix FIO with
Glutamax 1 (Gibco, Paisley, UK), supplemented with 15% fetal
bovine serum and 1% penicillin-streptomycin. The short term
cultures were harvested 16-72 h after induction ofthe culture. The
seeded cultures were regularly monitored and the medium changed
every three days, until sufficient growth was observed to facilitate
cytogenetic analysis. The adherent cells were removed by
trypsin/EDTA before harvesting according to recognized methods.
Slides were made from fixed cell suspensions and, following
ageing, were trypsin G-banded and Giemsa stained. The bone
marrow samples from cases 2 and 5 and the phytohaemagglutinin
(PHA)-stimulated peripheral blood investigation of case 5 and
his parents were cultured by recognized methods. Cytogenetic
analysis and interpretation was made according to ISCN 1995.
To establish if further evidence was present to indicate
instability, analysis was performed on the banded preparations of
cases 1-3 looking for spontaneous chromosomal breakage. The
morphology of chromosomes in cases 4 and 5 was too poor to
allow this analysis.
RESULTS
A cytogenetic result derived from the histiocytic lesion was
possible in all five cases (see Table 1), with analysis possible from
short-term cultures in cases 1 and 3. In four cases (1-4) non-clonal
acquired abnormalities were observed (Figure 1) and in one case
(3) a low level clone was also present. The abnormal metaphases
were either diploid or hypodiploid and unbalanced. Case 5 was
found to have an inversion of chromosome 13 in the biopsy and
bone marrow samples, which was subsequently proved to be
constitutional (Figure 2). The breakpoints of the inversion could
be defined as 13q21.2 and q33.
The cytogenetic investigation of the parents demonstrated that
the 13q inversion was maternally inherited. The father had a
normal 46,XY male karyotype.
The chromosome breakage study of cases 1-3 (see Table 2),
revealed a breakage level typically higher than that seen in like
cultures from other patients with neoplasms. The breakage seen
was usually small chromatid breaks and the only break seen on
more than one occasion was at 2q31. The characterized breaks
were then compared with known fragile sites to determine if any
pattern existed. It was found that 47% of breaks were located at
known group 1 common fragile sites, and nobands associated with
other fragile site types were affected. The figure of 47% is higher
than would be expected by chance at the 400-band level, although
it must be considered that if sub-band determination was possible
this figure is likely to be lower.
DISCUSSION
The description ofchromosomal abnormalities in LCH is rare and
is limited to case reports ofpatients with constitutional abnormali-
ties (Orye et al, 1982; Frost andWiersma, 1996). We believe this is
the first report that describes cytogenetic abnormalities in the LCH
lesions. Four cases were found to have either clonal or non-clonal
abnormalities in 2-18% ofanalysable metaphases. A fifth case had
no detectable acquired abnormalities in the lesion but did have a
Table 2 The number of metaphases containing acquired chromosomal aberrations in the analysis of histiocytic lesions
Case Total metaphases Metaphases with structural Metaphases with breaks Metaphases containing an
examined abnormalities abnormality (%)
1 33 6 4 27
2 44 1 6 16
3 50 5 11 30
4 12 2 ND 17
5 10 0 ND 0
ND, not done.
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constitutional abnormality. This particular case, although a histio-
cytosis was diagnosed, did not fulfil all the criteria for the LCH
subtype.
The karyotypes of two cases (1 and 3) were obtained from a
combination of short term and fast-growing long-term cultures
(5-8 days), thereby increasing the likelihood that it was LCH cells
that were analysed. It has been argued that LCH cells are difficult
to cultivate, which would raise the question of whether it was,
indeed, LCH cells that were analysed. This is clearly possible in
cases 2 and 5 in which analysis was only possible from slow-
growing long-term cultures. However, ifit were the case that LCH
cells were not analysed, then clearly aberrant processes are occur-
ring in the surrounding cells.
The patient (case 5) with the constitutional paracentric inversion
of 13q is the second reported case with histiocytosis and an abnor-
mality of 13q. The first case involved a deletion and was found in
conjunction with retinoblastoma (Orye et al, 1982). This may
suggest the presence of a gene on chromosome 13q that is
involved in histiocytic neoplasms. However, one must be careful
with this assertion as to our knowledge no other case has been
reported with a deletion of 13q and LCH.
It was recently demonstrated using X-inactivation studies, that
LCH is a clonal disease rather than the previously suspected poly-
clonal disorder (Willman et al, 1994; Yu etal, 1994). This provides
evidence that LCH may occurby a neoplastic process. Ourfinding
ofa karyotypic clone provides further evidence that LCH can be a
neoplastic disorder. However, there are diseases that are disputably
neoplastic in which clonal and non-clonal abnormalities have been
described. These include Dupuytren's contracture of the palm of
the hand and nasal polyps (Wurster-Hill et al, 1988; Vanni et al,
1996). Perhaps more significantly, our findings are not dissimilar
to those described in haemophagocytic lymphohistiocytosis
(HLH) by Kaneko et al (1995), who described clonal and non-
clonal abnormalities in this subtype of histiocytic disease. This
raises the possibility that the underlying mechanism ofhistiocytic
diseases is the same or similar.
LCH appears to be characterized by karyotypic instability that
may lead to the acquisition ofan aberration that confers a compet-
itive advantage resulting in clonal proliferation. However, what is
still unclear is the stimulus that promotes the chromosomal insta-
bility, and whether it is genetic, viral, or another environmental
factor. It may well be of interest to investigate how LCH cells
respond to various DNA damage-inducing agents. There is no
report ofa familial predisposition to LCH, which lends support to
the notion of an acquired abnormality, but does not exclude the
possibility that the parents are rare heterozygote carriers of a
specific recessive mutated gene.
There is clearly much work to be done in elucidating the cause
ofLCH. The findings above indicate one direction in which future
research into this disease can concentrate.
ACKNOWLEDGEMENTS
We thank the 'Zurcher Vereinigung zur Unterstutzung kreb-
skranker Kinder' for their financial support and Ken Roycroft for
his helpful discussion.
REFERENCES
Egeler RM, Neglia J, Puccetti DM, Brennen C and Nesbit ME (1993) The
association ofLangerhans cell histiocytosis with malignant neoplasms. Cancer
71: 865-873
Egeler RM, Neglia JP, Arico M, Favara BE, Heitger A and Nesbit ME (1994) Acute
leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol
23: 81-85
Frost JD and Wiersma SR (1996) Progressive Langerhans cell histiocytosis in an
infant with Klinefelter syndrome successfully treated with allogeneic bone
marrow transplantation. JPediatr Hematol Oncol 18: 396-400
Gadner H, Heitger A, Grois N, Gatterer-Menz I and Ladisch S (for the DAL HX-83
Study Group) (1994) Treatment strategy for disseminated Langerhans cell
histiocytosis. MedPediatr Oncol 23: 72-80
Greenberger JS, Croker AC, Vawter G, Jaffe N and Cassady JR (1981) Results of
treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome,
Schuller-Christian syndrome and multifocal eosinophilic granuloma). Medicine
60: 311-338
ISCN (1995): An Intemational System for Human Cytogenetic Nomenclature.
Mitelman F (ed), S. Karger: Basel
Kaneko Y, Maseki N, Ido M, Tsunematsu Y, Mizutani S, Hattori T, Shimizu H,
Eguchi H, Oka T, Miyake M, Horikoshi Y and Suchi T (1995) Clonal and non-
clonal karyotypically abnormal cells in haemophagocytic lymphohistiocytosis.
BrJHaematol 90: 48-55
Lichtenstein L (1953) Histiocytosis X: integration ofeosinophilic granuloma of
bone, 'Letterer-Siwe disease', and 'Schuller-Christian disease' as
manifestations ofa single nosologic entity. A MA Arch Pathol 56: 84-102
Ornvold K, Carstensen H, Larsen JK, Christensen IJ and Ralfkiaer E (1990) Flow
cytometric DNA analysis oflesions from 18 children with Langerhans cell
histiocytosis (histiocytosis X). Am JPathol 136: 1301-1307
Orye E, Benoit Y, Coppieters R, Jaennin P, Vercruysse C and Delbeke MJ (1982) A
case ofretinoblastoma, associated with histiocytosis-X and mosaicism ofa
deleted D-group chromosome (13q14 leads to q31). Clin Genet 22: 37-39
Rabkin MS, Wittwer CT, Kjeldsberg CR and Piepkom MW (1988) Flow-cytometric
DNA content ofhistiocytosis X (Langerhans cell histiocytosis). Am JPathol
131: 283-289
Vanni R, Marras S, Ravarino A, Faa G and Medda C (1996) Chromosome changes
in nonneoplastic tissue. Numerical and structural abnormalities in nasal polyps
with atypical stromal cells. Cancer Genet Cytogenet 88: 158-162
Willis B, Ablin A, Weinberg V, Zoger S, Wara WM and Matthay KK (1996) Disease
course and late sequelae ofLangerhans cell histiocytosis. J Clin Oncol 14:
2073-2082
Willman CL (1994) Detection ofclonal histiocytes in Langerhans cell histiocytosis:
Biology and clinical significance. BrJ Cancer70 (suppl. XXIII): S29-S33
Willman CL, Busque L, Griffin BB, Favara BE, McClain KL, Duncan MH and
Gilliland DG (1994) Langerhans'-cell histiocytosis (histiocytosis X) - a clonal
proliferative disease. New EnglJMed331: 154-160
Writing Group OfThe Histiocyte Society (1987) Histiocytic syndromes in children.
Lancet 1: 208-209
Wurster-Hill DH, Brown F, Park JP and Gibson SH (1988) Cytogenetic studies in
Dupuytren contracture. Am JHum Genet43: 285-292
Yu RC, Buluwela L and Chu AC (1994) Clonal proliferation ofLangerhans cells in
Langerhans cell histiocytosis. Lancet 343: 767-768
Yu RC and Chu AC (1995) Lack ofT-cell receptor gene rearrangements in cells
involved in Langerhans cell histiocytosis. Cancer75: 1162-1166
C CancerResearch Campaign 1998 British Journal ofCancer(1998) 77(4), 552-555